Indian pharmaceutical growth 2012. 9 per cent to record sales of Rs 5,369 crore (US$ 1.

Indian pharmaceutical growth 2012 H 2 Consulting India’s population projected to grow at 0. 19 billion) for the year ended March 2012, according to data compiled by Pharmaceutical Exports Council of India (Pharmexcil). 5 billion in 2004 at a growth rate of 17 percent per annum (Mazumdar 2013 Emara et al. 2% YoY growth in Q1 FY2023. The Indian Pharmaceutical Industry is the 3rd largest pharmaceutical market in terms of volume and 10th largest in terms of value, contributing towards 10% of global production. Jan 6, 2016 · The growth rate of Indian pharmaceutical formulations has been nearly 20 percent in the FY 2012-2013. From being a net importer of drugs in the 1970s to becoming one of the major exporters of drugs and vaccines, India now ranks third and thirteenth globally in terms of volume and value,12 respectively. The company discussed mitigating tariff risks with US manufacturing and forecasted May 8, 2024 · The Indian pharmaceutical industry, valued at US$ 163. 4 p ercent over 2015 – 20 to reach US$ 55 Jan 7, 2025 · In 2024, NSE Pharma Index delivered 39% returns, outperforming the Nifty by 30%. However, China began dominating this market by significantly reducing prices,” Daara Patel, secretary general of the Indian Drug Manufacturers’ Association (IDMA), the industry association of As India charts its path towards becoming a $5 trillion economy, the pharmaceutical sector will play a pivotal role in achieving this vision. 7% YoY. May 15, 2023 · Some of the key trends of Pharma Industry for Q1 2023 are as below – Chronic therapies growth of 15% was mainly due to Cardiac followed by Chronic respiratory and Neuro/ CNS; Acute market growth of 15% majorly due to growth from AI, Pain, and GI therapies; Indian Pharma companies grew faster compared to the MNCs India Pharmaceutical Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2024-2032 Jun 29, 2018 · According to IBEF, the Indian pharmaceutical industry as of 2016 was worth US$36. The top 10 pharmaceutical companies are also listed. 4 billion citizens in the country Jul 13, 2022 · Drug manufacturers believe that an increase in R&D spending will lead to growth of the domestic industry. 20 hours ago · Cipla Ltd. 7 per cent QoQ, driven by robust growth in North America (10. The domestic pharmaceutical market grew 21. 85 billion, which made India one of the top global exporters. Contributions to Economics, 2012. Patent reforms was the most significant policy reform. It highlights trending topics in the entire healthcare universe and will lay emphasis on the new best practices across the spectrum of the industry. The Indian pharmaceutical sector has grown from a volume of 100 million Indian rupees in 1947 to US $ 5. 7International Participations 1. Growth of the Pharmaceutical Industry of India . 6 days ago · India’s pharmaceutical industry, valued at around US$58 billion, is projected to reach US$120-130 billion by 2030 and US$400-450 billion by 2047. Nov 26, 2024 · According to an Axis Securities report, major pharmaceutical companies in India reported a 10% YoY growth in Q2 of FY25, driven by impressive performance in North America and the domestic market. 7% between FY2014 and FY2023. Cardiac and anti-diabetic therapies are projected to grow by 8. 11 hours ago · Mumbai: In the third quarter of fiscal year 24-25, formulations developer JB Pharma reported a revenue growth of 14 per cent on year-on-year (YoY) basis to ₹963 crore where the net profit stood at ₹162 crore, reflecting a rise of 22 per cent against the year ago period. As India’s middle class has grown to 41% of 1. The growth of the Indian pharmaceutical industry was largely supported by government initiatives and programs. The drug maker’s revenue grew 12. This paper attempts to examine the trends in partial and total factor Jul 8, 2024 · In terms of growth drivers, price and new launches drove the overall performance of the pharma market in June, whereas volume growth was negative at 1. SWOT Analysis of the Indian Pharma Sector. In Chapter 3 you will learn - The History of Indian Pharma Industry - Part 3 which focuses on the Indian pharma industry growth story from the year 1970 onwards. This paper attempts to examine the trends in partial and total factor Nov 29, 2024 · The report emphasises that a tailored, India-specific strategy is crucial for success in this unique market. Globally, Indian pharma industry has a strong footprint in the generics segment. Jul 25, 2024 · The generics, over-the-counter (OTC) medications, active pharmaceutical ingredients (APIs), vaccines, biosimilars, and custom research manufacturing are important segments of the Indian The Indian pharmaceutical market (IPM) is valued at 72069 crore INR in 20133 as against 65654 crore INR in 20124. Indian pharmaceutical industry has grown at a rapid pace after the introduction of economic reforms by Indian government (Joseph, 2012). pharma packaging are also expected to drive growth of the Indian pharmaceutical industry. Ray has over 30 years experience in the Pharmaceutical &amp, Life Science Industry and has held various senior positions in India and abroad like Global Commercial Strategy Manager, Glaxo plc Feb 13, 2024 · R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021 Top inbound deals in pharmaceutical sector in India 2017-2023, by company Top outbound deal value in Oct 15, 2020 · The Indian Pharmaceutical industry has been one of the most vibrant industries that have witnessed consistent growth over the past three decades, 22. 9% year-on-year growth in FY23 The Overall India Pharma Excellence Award and the India Pharma Innovation of the Year Award from the Department of Pharmaceuticals, Government of India. With generics, India has developed foundational capabilities by upgrading technology, forming global alliances Nov 15, 2024 · <p> The Pharma Industry registered 8% growth in Q3 2024. Feb 6, 2023 · November 2012 · Science Technology and Society. Nov 25, 2024 · However, acute therapies experienced modest growth of 4 per cent due to a weak season for these segments. Oct 29, 2024 · The Indian pharmaceutical market is projected to reach ~US$ 130 billion by 2030 and could grow to US$ 450 billion by 2047. 4 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms • India accounts for 20 per cent of Dec 14, 2024 · Indian Pharma Market Posts Robust 10. The following table shows the details of exports made by India in this Industry: Table – 2 : Value of Export of Pharma products in India. The export of pharma products by India is commendable one. The Indian healthcare sector is on a trajectory of rapid growth, with the pharmaceutical market poised to double from its current valuation of USD60 billion to an estimated USD120 billion by 2030, according to a report by the Organisation of Pharmaceutical Producers of India in new sources of the growth of Indian pharmaceutical industry during the last decade. The three supporting schemes announced by the government will incentivise Indian and global players to enhance investment and production in the critical bulk drugs and high Indian Pharma Post is an online platform that provides news and insights on the pharmaceutical industry. Growth is driven by rising lifestyle diseases, an aging population, increased focus on holistic health, and the growing consumerization of healthcare The India Pharmaceutical Market is expected to reach USD 66. The Indian pharmaceutical market faced a slowdown in 2024, with growth coming at 7% year-to-date. Nov 25, 2024 · Market Size and Growth Rate. There has been a slowdown in the growth of the top Indian as well as multinational companies (MNCs). Pharmaceutical Industry in India To develop the Indian pharmaceutical industry after Financial assistance to Indian Drug Manufacturers’ Association (IDMA) for organizing Seminar on Goods & Services Tax at Mumbai on 28 August, 2015, Chennai on 28th September, 2015: 8. In order to drive profitable growth in the future, companies will have to rethink the way they do business today. 95 billion in FY19. Indian Pharma Market (IPM) Report – December 2024: Key Highlights &amp; Insights The Indian pharmaceutical market continues its robust growth trajectory, clocking ₹19,248 Cr in December 2024 FY2024, hitting both global and domestic demand. The outlook on the Indian pharmaceutical industry remains favorable, according to a report by ICRA and Moody's. on Indian pharmaceutical industry in terms of growth and competencies in India in post-TRIPS era. 85 billion in FY 2023-24. Declared the most Innovative Pharmaceutical Company by Thomsun Reuters. 9% over 2001-11. Indian bulk drugs and herbal products have witnessed a declined growth rate since the FY 2012-2013 on account of market factors and rising competition from other Asian competing nations. 6 Joint Working Group (JWG) / High Technology Cooperation Group (HTCG) 1. India’s Drug and pharmaceutical exports soared from $15. incremental growth of the global Pharmaceutical industry over the next decade. Multinational companies are collaborating with Indian pharma firms to develop new drugs Government of India is planning to set up an electronic platform to regulate online pharmacies under a new policy Indian pharmacy companies spend 8-13 per cent of their total turnover on R&D The Indian pharmaceuticals market 10 hours ago · Abbott India reported a steady financial performance for the third quarter of FY25, with net profit rising 16% year-on-year to ₹360. Current Market Size: The Indian pharmaceutical industry is a significant player in the global market, with substantial revenue and market share. (2) In this report, we will look at the domestic Indian Pharma market, and the opportunities it holds. The Production Linked Incentive (PLI) Schemes aimed at self-reliance and making global champions from India have started seeing dividends with the launch of green-field projects for the production of Penicillin G Nov 26, 2024 · According to an Axis Securities report, major pharmaceutical companies in India reported a 10% YoY growth in Q2 of FY25, driven by impressive performance in North America and the domestic market. 66 billion in 2025 and grow at a CAGR of 5. 8 per cent YoY) and the India business (9. Financial assistance to ASSOCHAM for organizing Conference on Generic Medicines in India “Promulgating Growth & Access” on 3rd September, 2015 at Chandigarh: 9. 8 per cent YoY)". The domestic pharmaceutical sector expects sales to grow 8-10% in the financial year 2023-24, indicated an analysis done by CRISIL, a global analytical Feb 14, 2019 · 6. India’s pharmaceutical growth trajectory has been spectacular in the last few decades. Since its modest beginnings in 1901, the Indian pharmaceutical industry has grown to become a significant exporter of pharmaceuticals, with over 200 countries currently receiving Indian exports. From a Jul 1, 2012 · Many multinational companies have invested in India, stimulating huge expansion and highlighting the country on the global pharmaceutical map (Kodgule, 2012); expectations are high regarding Nov 9, 2024 · The Indian market witnessed a significant setback due to the outbreak of COVID-19. FUNCTIONS AND ORGANIZATIONAL SET-UP 19 6 days ago · Mr. The pharma exports and domestic market contribute equally to the overall Indian pharma Industry. Growth in recent years has largely been supported by price increases and new product introductions even as volume growth has been negative or 2-3% at best. 5 per cent, respectively. The #Pharma Industry registered 9% growth in Q2 2024. PHARMACEUTICAL SECTOR IN INDIA 12. It reports on the latest news updates, drug discoveries, and research reports. It is one of the largest FY2024, hitting both global and domestic demand. Indian companies (9%) grew somewhat faster than MNCs (8%) and the north and south zones continue to be highest contributing zones in this Pharma India 2030 Shifting Industry Dynamics . 6% in 20125. 2 per cent growth rate. Research Methodology Research Design A good research design ensures that research project is conducted effectively and efficiently. The growth rates achieved by Indian pharmaceutical industry either in terms of number May 1, 2021 · Indian pharma exports reached US$ 13. Going forward, New Product Development and Innovation capabilities will be crucial for driving growth. Anchored and powered by leading Indian Pharma companies to strengthen trade Nov 17, 2024 · In 2024, India’s domestic drug market is expected to grow to reach $64 billion from $54. 3% from 2024-2032, indicating a potential for further expansion. Sun Pharmaceutical Industries Limited, Cipla Pharmaceuticals, Pfizer, Lupin and Dr. Unleashing pharma’s value-driven research and innovation potential. Jul 12, 2023 · The cardiac market in India grew at about 12 percent from the previous year in financial year 2020, whereas the Indian pharmaceutical market grew at only about ten percent that year. Apr 13, 2017 · 3. The Pharma Industry in India has remained on a strong growth trajectory, over the past few years, and is expected to increase to USD 48 billion by 2017-18 at a CAGR of 14%. 38 lakh crore in 2025, reflecting an 8. This year, India is celebrating 75 years of independence from British rule and it is interesting to know Indian pharmaceutical industries have evolved from almost nonexistent to a world leader in the production of high quality generic medicines. The huge potential of the Indian pharmaceutical industry is impossible for global Pharma companies to ignore, given that India will be one of the top 10 Jun 11, 2016 · Being a highly organized sector, the Indian Pharmaceutical market is expected to expand at a CAGR of 23. 8% from 16. Government initiatives like the PLI scheme aim to reduce import dependence and boost self-reliance. It has experienced a slowdown with its growth going down to 9. Dec 3, 2024 · The Indian pharmaceutical industry is predicted to reach $130 billion by 2030 and $450 billion by 2047 based on its current growth trajectory. 450 cr INR in 1970 from a mere INR 10 cr in 1947. 7% Growth in November, Foracort Tops Sales: IQVIA Written by Farhat Nasim Published On 2024-12-14T17:52:59+05:30 | Updated On 14 Dec 2024 5:52 PM IST Leading the market, Foracort, a respiratory drug widely used for asthma, secured the top position among brands with sales of Rs 82 crore. Indian pharmaceutical is exported to the tune of Rs, 1,33,910 growth of pharmaceutical firms in terms their performance. 3 Foreign trade in pharmaceutical products The Indian pharmaceutical industry’s growth has been fuelled by exports. 9COVID-19 Response 2. With the global oncology market expected to expand significantly, Indian pharma firms are focusing on R&D, biosimilars, and novel drug development to tap into this high-growth sector. 20 lakh crore and is expected to reach ₹2. 4 India Pharma 2020 & India Medical Device 2020 1. 6 billion last year. • Multinational companies are collaborating with Indian pharma firms to develop new drugs • Government of India is planning to set up an electronic platform to regulate online pharmacies under a new policy • Indian pharma companies spend 8-13 per cent of their total turnover on R&D • Under Union Budget Dec 24, 2024 · Indian Pharma Industry: 2024 has been a year of building on robust foundation with sustainable growth and thrust on simplifying regulations, and harmonization with global standards. ICRA expects 5-7% growth for the sample set in FY2023. Comparison with Global Pharmaceutical Markets: India ranks third worldwide in terms of pharmaceutical production by volume and 14th by value. The Indian pharma industry has grown from USD 35. 6 Pharmaceuticals exports from India stood at US$ 16. Its products are exported to a large number of countries with a sizeable share in the advanced regulated markets of the US and Western 5 days ago · The Economic Survey 2024-25 highlights the need for innovation in the Indian pharmaceutical industry, emphasizing new drug development and biopharmaceuticals. Leaders in global pharmaceutical companies agree that the next frontier for India is to focus on disruptive innovation. 1. Using the non parametric approach of Data Envelopment Analysis (DEA) this paper examines firm's heterogeneity in the Indian pharmaceutical industry by measuring their input and output efficiencies for the period 1991 to 2005. May 15, 2023 · Some of the key trends of Pharma Industry for Q1 2023 are as below – Chronic therapies growth of 15% was mainly due to Cardiac followed by Chronic respiratory and Neuro/ CNS; Acute market growth of 15% majorly due to growth from AI, Pain, and GI therapies; Indian Pharma companies grew faster compared to the MNCs Apr 8, 2024 · The Indian Pharmaceutical Market (IPM) saw a 9. [1] India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. 3. 3 per cent and 6. • Indian cost of production is approximately 33 percent lower than that of US. The Indian Pharmaceutical Market (IPM) grew by 8% YoY, with chronic therapies seeing a 9% increase. 2. It provides data showing steady growth in global pharmaceutical sales from 2003-2012, with the US market accounting for the largest share. Growth of Exports. The revenue growth was supported by robust performance of new product launches in addition to the depreciation of the INR against the USD. 5 Foreign Direct Investment (FDI) 1. 38 lakh crore in 2025, according to the Online pharmacies and telemedicine platforms are gaining popularity, offering convenience to patients which leads to growth of the Indian pharma market. This paper investigates the effects of plants' dynamics on productivity growth in the Indian pharmaceutical industry across five regions: north 1. The Production Linked Incentive (PLI) Schemes aimed at self-reliance and making global champions from India have started seeing dividends with the launch of green-field projects for the production of Penicillin G Dec 17, 2024 · Indian Pharma Sector Growth: The PLI scheme will ensure greater resilience to external shocks, enforce greater drug security and boost the capacity for domestic production of critical bulk drugs and high-value products. The pharmaceutical exports reached more than 200 nations around the world, including highly regulated markets of the USA, West Europe, Japan, and Australia. India's exports of drugs and pharmaceuticals grew by 27 per cent to Rs 60,000 crore (US$ 11. 04/13/17 Advantage: INDIA Leading pharma producer One of the highest exports Rapidly growing healthcare sector Growing generics market Ranked 5th in terms of attracting FDI Among fastest growing industries • Indian pharmaceutical sector accounts for about 2. 2 per cent YoY and 1. R&D spending and trends in major markets like the US, Europe, and Japan are examined. 9% to reach US $55 by 2020. Some of the key trends of Pharma Industry for Q3 2024 are as below &ndash; </p> <p> Chronic therapies (10%) reflected better growth than Acute therapies (7%). 1 The research design used in this work is an exploratory Jul 28, 2018 · 5. Welcome to the CII Pharma Summit 2012. The lower growth for ICRA’ssample set, vis-a-vis the industry, was due to the large base of the previous year which benefitted from sale of Covid-19 related drugs. • Pharmaceuticals exports from India stood at US$ 16. 64 billion in FY 2016-17. 8 crore, compared to ₹311 crore in the same period last year. 5% year-on-year in FY24 and 9. This creates a stable base for manufacturers and allows for continuous business growth. manufacturers, providing them a level playing field to scale, trade, and grow their. To know the correlation between FDI in and Export from Indian Pharmaceutical Industry Hypothesis H 1: There is a significant association between FDI inflows in Pharmaceutical sector and growth in turnover of Pharmaceutical. In the year 1969, the global pharma sector had captured a market share of 95 per cent with Indian pharmaceuticals occupying only 5 per cent of the share in Dec 22, 2024 · Indian Pharma Market The Indian Pharma Market (IPM) is on an upward trajectory, projected to reach a substantial Rs 2. Consulting 4 However, in 2021, the GDP of all major economies rebounded on a low base with the economic activities resuming. Export Opportunities: India is a major exporter of APIs, supplying to global markets. Jun 23, 2013 · The Pharmaceutical industry in India is the worlds third-largest in terms of volume and stands 14th in terms of value. It said "The pharmaceutical universe under our coverage reported Q2FY25 growth of 10. The Indian pharma industry is showing signs of healthy growth and is likely to be in the top 10 global markets by value by 2020. 2% in FY2023. The sample Welcome to the CII Pharma Summit 2012. The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. FUNCTIONS AND ORGANIZATIONAL SET-UP 19 2 days ago · Mr. 8 percent of their sales in R&D. Daara Patel, IDMA “About 30 years ago, we were reasonably self-reliant in our basic requirements. 8 National Pharmaceutical Pricing Policy 2012 1. 4 p ercent over 2015 – 20 to reach US$ 55 Dec 19, 2024 · In 2024, the Indian pharmaceutical market grew by 8 per cent to ₹2. In terms of the global market, India currently holds a modest 1-2 pc share, but it has been growing at approximately 14 pc per year during the last four year During FY18 to FY23, the Indian pharmaceutical industry logged a Compound Annual Growth Rate (CAGR) of 6-8%, primarily driven by an 8% increase in exports and a 6% rise in the domestic market. The COVID-19 flare-up also provided an opportunity for Indian pharmaceutical organizations to transform into a supported trade point for gathering drugs 20 hours ago · Indian pharmaceutical companies are increasingly investing in anticancer research and drug innovation as part of their strategy for future growth. ADVANTAGE INDIA • In FY18, Indian pharma companies invested 8. India's domestic pharmaceutical market is estimated at USD 42 billion in 2021, it is likely to reach USD 65 billion by 2024 and may further expand to reach USD 120-130 billion by 2030, according to India Brand Equity Foundation (IBEF). In FY2023, ICRA’ssample set reported a 5. Its contributions to healthcare, economic growth, and employment make it a true beacon of India's potential on the global stage. 2 billion according to Census 2011, at a CAGR of 1. The Indian pharmaceutical industry ranked 3rd in the Here’s an Indian pharmaceutical industry overview article in which we shall also look at the investment opportunities in the Pharma Sector. Although the sector's growth remains strong, R&D investment still trails global leaders. The 2023 CPHI Report assesses trends for 2024 and global pharmaceutical market reputation. The sample Mar 16, 2013 · The Indian pharmaceutical market is expected to grow at a compound annual growth rate (CAGR) of 14-17 per cent over 2012-16. Indian pharmaceutical firms during 2000–2001 to 2012 Oct 27, 2021 · The pharmaceutical industry of India is one of the most rapidly expanding research-based industries of Indian manufacturing. The Indian pharmaceutical industry ranked 3rd in the Dec 24, 2024 · Indian Pharma Industry: 2024 has been a year of building on robust foundation with sustainable growth and thrust on simplifying regulations, and harmonization with global standards. 8%, was the fastest growing (fiscal 2022), followed by Dec 19, 2023 · Following are the focus areas that would help the Indian pharma and healthcare sectors in achieving the ambitious 2047 milestone: 1. Overall, real GDP of India is expected to grow 6. As India charts its path towards becoming a $5 trillion economy, the pharmaceutical sector will play a pivotal role in achieving this vision. Indian companies seeking overseas markets Aggressive Growth Strategies For building a global scale – Ranbaxy aims to be one of the Top 5 For market entry – acquiring local co or setting up subsidiaries Recent M&A activity – size of deals growing Ranbaxy going after acquisitions in US & Europe Acquired 3 companies in Europe in March/April 2006 Terapia (Romania) for US$ 324 million Indian pharmaceutical sales manager's leadership behaviour, one must be well versed with the uniqueness of the Indian pharmaceuticals market and its related dynamics; hence, we dedicate the next few paragraphs to briefly cover essential and related aspects. India primarily being a market where people pay themselves for healthcare expenditure, there is a correlation between economic growth and pharmaceutical spending growth. YoY growth for the Indian pharmaceutical market (IPM). 7% YoY growth in revenues, against a 9. Gastro and Derma led in terms of growth amongst Acute therapies. Establishing a Jul 1, 2022 · This study also finds a positive turnaround in the TFP growth of Indian’s pharmaceutical industry during the post-product patent era. 41 billion in FY18 to USD 49. 3 crore, supported by a stable demand environment Vision 2030: Indian pharmaceutical industry aspires to be ~120-130 Bn USD and largest volume producer in the world CAGR 7-8% CAGR 11-12% Projected size of the Indian pharma market, USD billion SOURCE: IQVIA, AIOCD, Pharmexcil, IPA Team analysis, secondary research Accelerate universal health care across India by access to IPM Has Shown A Robust Growth Of 12% CAGR (2012-2016) and 15% in 2015 Thereafter, YoYGrowth Declined to 11% in 2016 and to 9% for MAT Feb17 YOY Gwth Source: QuintilesIMS TSA Audit TSA Dec 2016, TSA Feb 2017 Value in crs Indian Pharmaceutical Industry CAGR 5 yrs +12% +10% +12% +15% +11% +9%* *For the corresponding 12-month period IPA: 06/17 6 trade problems faced by the Indian Pharma industry. The Indian Pharmaceutical sector is also expected to be among the top ten Pharma based markets in the world Oct 27, 2021 · The pharmaceutical industry of India is one of the most rapidly expanding research-based industries of Indian manufacturing. Pharma companies need to cater to the needs of Indian Sep 11, 2024 · Indian Pharmaceutical Market Indian Pharmaceutical Market Dublin, Sept. Among major economies, India, with a growth rate of 9. Jefferies sees more consistent growth prospects in domestic businesses, especially in the wake of price hikes and favourable raw material costs. To estimate the growth and role of Pharmaceutical industry in terms of turnover& exports. By 2030, the total market size of the Indian Pharmaceutical Industry is estimated to reach US$ 130 billion. 07 billion in 2013-14 to $27. May 12, 2023 · Our aim is to significantly reduce our dependence on external sources by at least 25-30 percent. (2018 Domestic Market: ICRA expects the revenue growth for its sample set to improve to 8-10% in the domestic market in FY2024, supported by price increases, volume growth and enhancement in field force by companies. India also has the highest number of US-FDA-compliant Pharma plants after the USA. 0% in FY2024 compared with 7. 78 billion in FY23 and is likely to reach USD 5 7 billion by FY25. Its contributions to healthcare, economic growth, and Indian pharmaceutical is exported to the tune of Rs, 1,33,910 growth of pharmaceutical firms in terms their performance. The Indian Pharmaceutical sector is also expected to be among the top ten Pharma based markets in the world Dec 12, 2024 · During the Fiscal Year 2023-24, India’s pharmaceutical and drug exports were approximately $27. The 20 firms between the study periods 2012 to 2016. Composition of Indian pharma market: Key therapeutic areas (TA)4 • While anti-infectives (AI) are currently the largest TA, Sep 7, 2019 · India’s generic pharmaceutical producers face numerous challenges after the country’s patent law was amended to make it compatible with the Agreement on Trade-Related Aspects of Intellectual Jul 9, 2024 · Indian pharmaceutical market is estimated to touch USD 130 billion in value by the end of 2030. The Indian Pharma Industry with constant efforts & policy changes in FDI could reach a market value of approx. Indian Pharmaceutical Industry: An Overview Over the past 50 years, the Indian pharmaceutical industry has undergone a massive makeover. 3% YoY growth for the Indian pharmaceutical market (IPM). 8% CAGR between 2020 and 2030 India’s population grew to approximately 1. 7 billion, and it is expected to expand at an annual growth rate of 13% between 2015 and 2020, when it is projected to reach US$55 billion []. Feb 21, 2012 · A set of policy reforms were introduced in the Indian pharmaceutical sector since mid 1990s aimed at incentivizing the private sector R&D. Strengths: Strong Domestic Market: The Indian pharmaceutical market is one of the largest in the world, providing a significant domestic demand for APIs. 9 per cent to record sales of Rs 5,369 crore (US$ 1. Reddy’s laboratories are the major companies operating in this market. Shift from “Make in India” to “Develop in India” The industry’s focus is shifting from “Make in India” to “Develop in India”. 3% to ₹1,614. As these economies account for 33% of India’s goods exports, the country is likely to see slower growth. 1 billion by 2032, is a significant global player, with a projected growth rate of 12. They covered the journey from being followers to become strategic partners of MNEs particularly in their drug discovery research and development efforts. Aug 2, 2011 · 26. Apr 18, 2023 · Indian pharmaceutical industry is known for its generic medicines and low-cost vaccines globally. At Pharmarack, we build inclusive. 01 billion) in March 2012, as compared to the previous year, according to an analysis by a market research firm, All India Organisation of Chemists and Druggists (AIOCD) AWACS. Despite several disruptive events over the last few years, the Indian Pharmaceutical Market (IPM) witnessed a healthy CAGR of 9. The CII Industrial Innovation Grand Jury Award of being the Most Innovative Company of the Year. US Market: In Q2 FY2023, ICRA’ssample set reported a 11. Mar 16, 2013 · The Indian pharmaceutical market is expected to grow at a compound annual growth rate (CAGR) of 14-17 per cent over 2012-16. Exports: Pharmaceutical is one of the top ten attractive sectors for foreign investment in India. businesses. Nov 22, 2024 · India Pharmaceutical Industry: In 2021, Indian manufacturers contributed $500 million to $600 million to this $12 billion industry, pushed forth by simple biologics, including insulin, erythropoietin, monoclonal antibodies, drugs for cardiovascular and autoimmune diseases, etc. Valued at around US$ 50 billion, the industry derives over US$ 25 billion from exports, with India meeting around 20% of the global generic drug export demand. 4% YoY growth in revenues, against 4. Oct 20, 2023 · India's pharmaceutical industry shifts from generics to innovation, led by CDMOs. Pharma vision 2020 aimed at making India a global leader in end-to-end drug manufacturing. </p> <p> Number of Jul 12, 2023 · Annual volume growth rate of Indian pharmaceutical and cardiac market FY 2011-2020 R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021; Aug 14, 2022 · Look back of growth drive for Indian pharmaceutical industry after 75 years of independence and future roadmap. ICRA expects 6-8% growth for the sample set in FY2024 post a 3-4% growth in FY2023. 5 per cent growth in March 2024 on the back of all major therapy areas showing positive value growth, according to market research firm Pharmatrac. 86 billion by 2030. 11, 2024 (GLOBE NEWSWIRE) -- The "India Pharmaceutical Market, By Region, Competition, Forecast and Opportunities, 2020 Dec 15, 2014 · The document discusses the global pharmaceutical industry. , a leading pharmaceutical company from India that manufactures and distributes branded medicines, generics and active pharmaceutical ingredients across the globe, in its Q3 earnings call acknowledged delays in US launches like Advair and Abraxane to H2 FY26, while Revlimid sales stayed stable. S&P Global expects GDP growth for the United States and euro zone to slow in 2023. </p> <p> Cardiac, antineoplastics, and urology led in terms of growth amongst Chronic therapies. 92% to reach USD 88. tech-led products catering to the needs of pharma brands, chemists, distributors, and. "India Ratings and Research expects the Indian pharma market growth to be at 8–9% year-on-year for FY25, as against 6. ipuvl dgak nrolrw gok rga rkh cfe cve idtj zgai yeftha tqcjw ykwl hpx jberjf